维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Mackenzie MJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Factors influencing the decision to amputate or reconstruct after high-energy lower extremity trauma显示文摘	MacKenzie EJ Bosse MJ Kellam JF	2002	J Trauma2002，52，4：	1
2	A prospective evaluation of the clinical utility of the lower-extremity injury-severity scores显示文摘	Bosse MJ MacKenzie EJ Kellam JF	2001	J Bone Joint Surg Am2001，83，1：	1
3	Pseudopheochromocytoma显示文摘	Mackenzie IS Brown MJ	2007	J Hypertens2007，25，11：	1
4	Adult respiratory distress syndrome,pneumonia,and mortality following thoracic injury and a femoral fracture treated either with intramedullary nailing with reaming or with a plate:a comparative study显示文摘	Bosse MJ MacKenzie EJ Riemer BL	1997	J Bone Joint Surg(Am)1997，79，：	1
5	Research strategies for capturing transactional models of development:the limits of the possible显示文摘	Sameroff AJ Mackenzie MJ	2003	Dev Psychopethol2003，15，3：	1
6	Density dependence in cereal aphid populations 显示文摘	Maudsley MJ Mackenzie A Thacker JI	1996	Annals of Applied Biology1996，128，3：	1
7	Functional outcomes following trauma-related lower-extremity amputation显示文摘	MacKenzie EJ Bosse MJ CastiLlo RC	2004	J Bone Joint Surg (Am)2004，86，8：	1
8	Molecular therapy in Pancreatic adenocarcinoma显示文摘	MacKenzie MJ	2004	Lancet Oneol2004，5，3：	1
9	Primary anti- vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and sub- sequent therapy显示文摘	Heng DY Mackenzie MJ Vaishampayan U'N	2012	Ann Oncol2012，23，6：	1
10	Report of the consensus conference on antibiotic resistance; prevention and control (ARPAC) 显示文摘	Mackenzie FM Struelens MJ Towner K J	2005	Clin Microbiol Infect2005，11，11：	1
11	Adult respiratory distress syndrome pneumonia,and mortality following thoracic injury and a femoral fracture treated either with intrsmedullary nailing with reaming or waith aplate显示文摘	Bosse MJ Mackenzie EJ Riemer BL	1997	J Bone Joint Surg(Am)1997，79，6：	1
12	A phase Ⅱ trial of ZD1839(Iressa)750 mg per day,an oral epidermal growth factor receptor-tyrosine kinase inhibitor,in patients with metastatic color-ectal cancer显示文摘	Mackenzie MJ Hirte HW Glenwood G	2005	Invest New Dnigs2005，23，2：	1
13	Metieillin-resist- ant Staphylococcus aureus (MRSA) : Screening and decolonisa- tion显示文摘	Cookson B Bonten MJ Mackenzie FM	2011	Int J Antimicrob Agents2011，37，3：	1
14	An analysis of outcomes of reconstruction or amputation of leg-threatening injuries显示文摘	Bosse MJ MacKenzie EJ Kellam JF		0，，：	1
15	Molecular therapy in pancreatic adenocarcinoma显示文摘	MacKenzie MJ	2004	Lancet Onco12004，5，9：	1
16	Inhibition of JAKs in Macrophages Increases Lipopolysaccharide-Induced Cytokine Production by Blocking IL-10-Mediated Feedback显示文摘	Pattison MJ MacKenzie KF Arthur JS	2012	The Journal of Immunology2012，189，6：	1
17	Early predictors of longterm work disability after major limb trauma显示文摘	MacKenzie EJ Bosse MJ Kellam JF		0，，03：	1
18	Long-term persistence of disability following severe lower-limb trauma:results of a seven-year follow-up 显示文摘	Mackenzie EJ Bosse MJ Pouak AN	2005	J Bone Joint Surg(Am)2005，87，：	1
19	An anatysis of outcomes of reconstruction or amputation after leg-threatening injuries显示文摘	Bosse MJ MacKenzie EJ Kellam JF	2002	N Engl J Med2002，347，24：	1
20	A phase Ⅱ trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer显示文摘	Mackenzie MJ Hirte HW Glenwood G	2005	Invest New Drugs2005，23，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示